HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating for AngioDynamics (NASDAQ:ANGO) and maintained a price target of $14.
October 04, 2024 | 5:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating for AngioDynamics and maintained a price target of $14, indicating confidence in the company's potential for growth.
The reiteration of a Buy rating and maintenance of a $14 price target by a reputable analyst suggests a positive outlook for AngioDynamics. This could lead to increased investor confidence and potentially a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100